跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-TRANDOLAPRIL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-TRANDOLAPRIL
Authorized
STANDARD
TEVA-TRANDOLAPRIL
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
357b6dcd4ad8647f
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
357b6dcd4ad8647f
Drug Approval Canada Name
TEVA-TRANDOLAPRIL
Product Name
TEVA-TRANDOLAPRIL
Status
Marketed
Status Date
2018-09-26
Original Market Date
2018-09-26
Din
02415445
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09AA10 TRANDOLAPRIL
Atc Name
c 09 aa 10
Aig Number
0131524003
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
TRANDOLAPRIL
2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
357b6dcd4ad8647f
Type
Standard
Back to Health Canada Approvals